Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Dermatol Sci ; 50(3): 217-25, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18243665

RESUMO

BACKGROUND: Mycosis fungoides (MF) is a T cell neoplasm with elevation of serum Th2 chemokines. Although interferon-gamma (IFN-gamma) administration and narrowband-UVB (NB-UVB) phototherapy are used for the treatment of MF, a combination therapy of these two modalities is not fully established. OBJECTIVES: To define whether the combination of IFN-gamma and NB-UVB affects the balance of serum levels of Th1 and Th2 chemokines in patients with MF. METHODS: Twelve patients with MF received intravenous or intramuscular injections of recombinant IFN-gamma (rIFN-gamma) or natural IFN-gamma (nIFN-gamma) in combination with NB-UVB phototherapy. As control, three MF patients were treated with NB-UVB monotherapy. At the beginning and cessation of therapy, the concentrations of serum Th2 chemokines, TARC/CCL17 and MDC/CCL22, and Th1 chemokines, IP-10/CXCL10 and MIG/CXCL9 were measured by ELISA. RESULTS: Before treatment, not only Th2 chemokines but also Th1 chemokines were elevated in the patients. Whereas no significant changes were observed in the levels of TARC and MDC, IP-10 and MIG were further elevated by the combination of IFN-gamma and NB-UVB. On the other hand, NB-UVB monotherapy did not change the level of either Th1 or Th2 chemokine. CONCLUSIONS: The combination of IFN-gamma and NB-UVB elevated serum Th1 chemokines but unaffected Th2 chemokines. Since NB-UVB monotherapy could not affect the chemokine levels, the effect of the combination therapy is attributable to IFN-gamma. Given the role of Th1 chemokines for tumor-attacking T cell recruitment at the early stage of MF, the therapy may exert a beneficial effect for early MF.


Assuntos
Interferon gama/administração & dosagem , Micose Fungoide , Neoplasias Cutâneas , Células Th1/metabolismo , Células Th2/metabolismo , Terapia Ultravioleta , Idoso , Idoso de 80 Anos ou mais , Quimiocina CCL17/sangue , Quimiocina CCL22/sangue , Quimiocina CXCL10/sangue , Quimiocina CXCL9/sangue , Terapia Combinada , Feminino , Humanos , Contagem de Linfócitos , Masculino , Pessoa de Meia-Idade , Micose Fungoide/tratamento farmacológico , Micose Fungoide/imunologia , Micose Fungoide/radioterapia , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/radioterapia , Células Th1/efeitos dos fármacos , Células Th1/efeitos da radiação , Células Th2/efeitos dos fármacos , Células Th2/efeitos da radiação , Resultado do Tratamento
2.
Eur J Dermatol ; 18(6): 710-3, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18955208

RESUMO

A 74-year-old Japanese man developed erythema multiforme on the inner aspect of his left elbow where ketoprofen-containing tape was applied and exposed to sunlight, and the eruption subsequently spread to the four limbs and trunk. The lesions were successfully treated with systemic corticosteroids without recurrence. Lymphocyte stimulation tests with ketoprofen-photomodified peripheral blood mononuclear cells revealed that the patient had circulating lymphocytes reactive with a photohaptenic moiety of ketoprofen. To our knowledge, this is the first case of erythema multiforme induced by photocontact dermatitis. The presence of circulating photoantigen-reactive T cells seemed to induce erythema multiforme as an unusual manifestation in this patient.


Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos , Dermatite Fotoalérgica/etiologia , Eritema Multiforme/induzido quimicamente , Cetoprofeno/efeitos adversos , Idoso , Dermatite Fotoalérgica/diagnóstico , Dermatite Fotoalérgica/imunologia , Dermatite Fotoalérgica/patologia , Eritema Multiforme/patologia , Humanos , Ativação Linfocitária , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA